These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 11232489

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
    Farthing MJ.
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Irritable bowel syndrome: pathophysiology and (future) treatment options].
    de Schryver AM, Samsom M.
    Ned Tijdschr Geneeskd; 2002 Jan 05; 146(1):12-7. PubMed ID: 11802330
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic and therapeutic strategies in the irritable bowel syndrome.
    Cremonini F, Talley NJ.
    Minerva Med; 2004 Oct 05; 95(5):427-41. PubMed ID: 15467518
    [Abstract] [Full Text] [Related]

  • 10. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.
    De Ponti F, Tonini M.
    Drugs; 2001 Oct 05; 61(3):317-32. PubMed ID: 11293643
    [Abstract] [Full Text] [Related]

  • 11. Treatment options in irritable bowel syndrome.
    Farthing MJ.
    Best Pract Res Clin Gastroenterol; 2004 Aug 05; 18(4):773-86. PubMed ID: 15324713
    [Abstract] [Full Text] [Related]

  • 12. New and emerging treatments for irritable bowel syndrome and functional dyspepsia.
    Talley NJ.
    Expert Opin Emerg Drugs; 2002 May 05; 7(1):91-8. PubMed ID: 15989538
    [Abstract] [Full Text] [Related]

  • 13. Tegaserod: a novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome.
    Beglinger C.
    Int J Clin Pract; 2002 May 05; 56(1):47-51. PubMed ID: 11831835
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Emerging treatments for irritable bowel syndrome.
    Ahn J, Ehrenpreis ED.
    Expert Opin Pharmacother; 2002 Jan 05; 3(1):9-21. PubMed ID: 11772329
    [Abstract] [Full Text] [Related]

  • 16. Drug treatment options for irritable bowel syndrome: managing for success.
    Dunphy RC, Verne GN.
    Drugs Aging; 2001 Jan 05; 18(3):201-11. PubMed ID: 11302287
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.